SEC Form 4 · accession 0001127602-18-025370
PDS Biotechnology Corp · PDSB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Albert N Marchio II
Officer — Chief Accounting & Adm Officer
Period of report
Aug 14, 2018
Accepted (ET)
Aug 15, 2018 · 7:59 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001472091
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2,F3 | — | Aug 14, 2018 | A | 41,666 | A | — | — | Common Stock | 41,666 | 41,666 | D |
Explanation of responses
- F1Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
- F2These options shall become exercisable upon the achievement of certain performance or time based criteria.
- F3Expiration date is not applicable as the vested Restricted Stock Units shall be settled on the first business day following the date that such Restricted Stock Units vest.